NCT03822546View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes With Nicotine Salt Formulations

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Healthy Volunteers
Interventions
OTHER

Conventional cigarette

Subject's own conventional cigarette brand smoked with puffs taken at 30 seconds intervals

OTHER

myblu 25 mg freebase

E-cigarette used for 10 inhalations every 30 seconds

OTHER

myblu 16 mg nicotine salt

E-cigarette used for 10 inhalations every 30 seconds

OTHER

myblu 25 mg nicotine salt

E-cigarette used for 10 inhalations every 30 seconds

OTHER

myblu 40 mg nicotine salt

E-cigarette used for 10 inhalations every 30 seconds

OTHER

blu PRO 48 mg nicotine salt

E-cigarette used for 10 inhalations every 30 seconds

Trial Locations (1)

68502

Celerion, Lincoln

All Listed Sponsors
lead

Fontem Ventures BV

INDUSTRY

NCT03822546 - A Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes With Nicotine Salt Formulations | Biotech Hunter | Biotech Hunter